Taken together, these results suggest that ANXA3 knockdown decreases the highly metastatic mesenchymal-like BCSCs but enriches the highly proliferative epithelial-like BCSCs, which might explain why the ANXA3 knockdown inhibited cancer cell invasion and tumor metastasis but promoted cancer cell proliferation and tumor growth. Here, ANXA3 is linked to cancer.